Literature DB >> 32767329

Axillary web syndrome in women after breast cancer surgery referred to an Oncological Rehabilitation Unit: which are the main risk factors? A retrospective case-control study.

A de Sire1, L Losco, C Cisari, A Gennari, R Boldorini, N Fusco, E Cigna, M Invernizzi.   

Abstract

OBJECTIVE: Axillary web syndrome (AWS) is a complication of surgical procedures in breast cancer (BC) patients. This condition with poorly understood incidence and etiology is characterized by the locoregional development of scar tissue, leading to subcutaneous cording, motion impairment and pain. The early identification of patients at risk for AWS would improve their clinical management. Here, we sought to characterize the prevalence of and the risk factors associated with AWS in BC women after surgery. PATIENTS AND METHODS: All patients with BC that underwent axillary surgery referred to an Outpatient Service for Oncological Rehabilitation were retrospectively collected. These women were assessed two weeks after the surgical procedure for their clinicopathologic features, type of therapeutic interventions, and AWS presence, laterality, pain, localization, cords type, and number of cords.
RESULTS: Altogether, 177 patients (mean aged 60.65 ± 12.26 years) were included and divided into two groups: AWSPOS (n=52; 29.4%) and AWSNEG (n=125; 70.6%). Patients with tumor N ≥1 (OR=3.7; p<0.001), subjected to mastectomy, axillary lymph node dissection (ALND) and chemotherapy showed significant correlations with AWS onset (p<0.05). The range of shoulder motion limitation (OR=11.2; p<0.001) and the presence of breast cancer related lymphedema (OR=3.5; p=0.020) were associated with AWS.
CONCLUSIONS: Mastectomy, ALND, chemotherapy, low staging tumors, shoulder range of motion limitations, and BCRL represent risk factors for AWS onset. Realizing new strategies for assessing the individual risk of AWS is a crucial clinical need to improve the health-related quality of life of BC survivors.

Entities:  

Mesh:

Year:  2020        PMID: 32767329     DOI: 10.26355/eurrev_202008_22486

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  15 in total

1.  Breast cancer-related lymphedema and its treatment: how big is the financial impact?

Authors:  Tessa De Vrieze; Nick Gebruers; Ines Nevelsteen; Wiebren A A Tjalma; Sarah Thomis; An De Groef; Lore Dams; Vincent Haenen; Nele Devoogdt
Journal:  Support Care Cancer       Date:  2020-11-24       Impact factor: 3.603

2.  Longitudinal changes in sports activity from pre-diagnosis to first five years post-diagnosis: a prospective Chinese breast cancer cohort study.

Authors:  Yuan-Yuan Lei; Suzanne C Ho; Carol Kwok; Ashley Cheng; Ka Li Cheung; Roselle Lee; Winnie Yeo
Journal:  BMC Cancer       Date:  2020-10-19       Impact factor: 4.430

Review 3.  Reconstruction of the Nose: Management of Nasal Cutaneous Defects According to Aesthetic Subunit and Defect Size. A Review.

Authors:  Luigi Losco; Alberto Bolletta; Diletta Maria Pierazzi; Davide Spadoni; Roberto Cuomo; Marco Marcasciano; Enrico Cavalieri; Ana Claudia Roxo; Paola Ciamarra; Carmen Cantisani; Emanuele Cigna
Journal:  Medicina (Kaunas)       Date:  2020-11-25       Impact factor: 2.430

4.  The Combination of Lymph Node Transfer and Excisional Procedures in Bilateral Lower Extremity Lymphedema: Clinical Outcomes and Quality of Life Assessment with Long-Term Follow-Up.

Authors:  Luigi Losco; Alberto Bolletta; Alessandro de Sire; Shih-Heng Chen; Gokhan Sert; Dicle Aksoyler; Jonathan Velazquez-Mujica; Marco Invernizzi; Emanuele Cigna; Hung-Chi Chen
Journal:  J Clin Med       Date:  2022-01-24       Impact factor: 4.241

5.  Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials.

Authors:  Alessandro de Sire; Lorenzo Lippi; Konstantinos Venetis; Stefania Morganti; Elham Sajjadi; Claudio Curci; Antonio Ammendolia; Carmen Criscitiello; Nicola Fusco; Marco Invernizzi
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

6.  Quality of Life Predictors in Patients With Melanoma: A Machine Learning Approach.

Authors:  Monica Pinto; Nicola Marotta; Corrado Caracò; Ester Simeone; Antonio Ammendolia; Alessandro de Sire
Journal:  Front Oncol       Date:  2022-03-25       Impact factor: 6.244

7.  Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study.

Authors:  Marco Invernizzi; Alessandro de Sire; Lorenzo Lippi; Konstantinos Venetis; Elham Sajjadi; Francesca Gimigliano; Alessandra Gennari; Carmen Criscitiello; Carlo Cisari; Nicola Fusco
Journal:  Front Oncol       Date:  2020-10-21       Impact factor: 6.244

8.  High-intensity interval training in breast cancer survivors: a systematic review.

Authors:  Katsunori Tsuji; Yutaka J Matsuoka; Eisuke Ochi
Journal:  BMC Cancer       Date:  2021-02-22       Impact factor: 4.430

9.  Rehabilitation interventions to support return to work for women with breast cancer: a systematic review and meta-analysis.

Authors:  Naomi Algeo; Kathleen Bennett; Deirdre Connolly
Journal:  BMC Cancer       Date:  2021-08-05       Impact factor: 4.430

10.  Physical Exercise with or without Whole-Body Vibration in Breast Cancer Patients Suffering from Aromatase Inhibitor-Induced Musculoskeletal Symptoms: A Pilot Randomized Clinical Study.

Authors:  Alessandro de Sire; Lorenzo Lippi; Antonio Ammendolia; Carlo Cisari; Konstantinos Venetis; Elham Sajjadi; Nicola Fusco; Marco Invernizzi
Journal:  J Pers Med       Date:  2021-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.